Our finding that c-Jun rather promotes NASH and fibrosis somehow antagonizing its effects in hepatocytes adds a novel level of complexity to AP-1-related signalling pathways in the liver. Here, JUNB is linked to metabolic dysfunction-associated steatohepatitis.